Assoc. prof. Solárová Zuzana, M.D., PhD
Research/art/teacher profile
Date of last update: 22.10.2026
I. Basic information
| I.1 Surname |
Solárová |
|---|---|
| I.2 Given name |
Zuzana |
| I.3 Degrees |
Assoc. prof. , M.D., PhD |
| I.4 Year of birth |
1974 |
| I.5 Name of the workplace |
University of Veterinary Medicine and Pharmacy in Košice |
| I.6 Address of the workplace |
Komenského 73, 041 81 Košice, Slovak Republic |
| I.8 E-mail address | zuzana.solarova@upjs.sk |
| I.9 University staff register / partner university profile | https://www.portalvs.sk/regzam/detail/15120?mode=full |
| I.10 Study field in which the person works |
Pharmacy |
| I.11 ORCID iD | 0000-0002-4212-5720 |
II. Higher education and further qualification growth
| Institution | Year | Study field and programme | |
|---|---|---|---|
| Second degree higher education | Pavol Jozef Šafárik University, Faculty of Medicine | 1998 | general medicine |
| Third degree higher education | Pavol Jozef Šafárik University, Faculty of Medicine | 2013 | clinical pharmacology |
| Habilitation procedure | Pavol Jozef Šafárik University, Faculty of Medicine | 2021 | pharmacology |
III. Current and previous employment
| Occupation | Institution | Year |
|---|---|---|
associated professor | Department of pharmacology | 2021 – to date |
assistent professor | Department of pharmacology | 2012 – 2021 |
assistent professor | Geriatric Nursing Clinic | 2004 – 2012 |
doctor | Louis Pasteur University Hospital, Košice | 1998 – 2004 |
IV. Development of pedagogical, professional, language, digital and other skills
| Activity | Institution | Year |
|---|---|---|
English language - advanced | Pavol Jozef Šafárik University, Philosophical Faculty |
V. Overview of activities within the teaching career at the university
Academic year: 2026/2027
V.1. Overview of taught profile courses
| Profile course | Study programme | Degree | Study field |
|---|---|---|---|
Clinical pharmacology and pharmacotherapy | Pharmacy (joint study programme with UPJŠ) – full-time study, Slovak language | I. + II. | Pharmacy |
V.2. Responsibility for the delivery, development and quality assurance of study programmes
No records yet.
V.3. Responsibility for the development and quality of habilitation and inauguration fields
No records yet.
V.4. Overview of supervised theses
| Bachelor | Master | Doctoral | |
|---|---|---|---|
| Currently supervised theses | 0 | 4 | 0 |
| Defended theses | 7 | 6 | 0 |
V.5. Overview of other taught courses
| Course | Study programme | Degree | Study field |
|---|---|---|---|
Clinical pharmacology and pharmacotherapy | Pharmacy – full-time study, Slovak language | I. + II. | Pharmacy |
VI. Overview of research/artistic/other outputs
The last six completed calendar years: 2020–2025. The current year is excluded.
VI.1. Overview of research/artistic/other outputs and citations
| Total | Over the last six years | |
|---|---|---|
| VI.1.1 Number of research/artistic/other outputs | 80 | 18 |
| VI.1.2 Number of outputs registered in Web of Science or Scopus | 17 | 6 |
| VI.1.3 Number of citations corresponding to research/artistic/other outputs | 433 | 355 |
| VI.1.4 Number of citations registered in Web of Science or Scopus | 269 | 225 |
| VI.1.5 Number of invited lectures at international and national level | 12 | 2 |
VI.2. The most significant research/artistic/other outputs
| 1. | SOLÁROVÁ, Zuzana, KELLO, Martin, SOLÁR, Peter: Apoptotic effect of homobrassinin and thiazino[6,5-b]indol is associated with downregulation of heat shock proteins in human ovarian adenocarcinoma cells. Acta Chimica Slovenica. - ISSN 1318-0207. - Roč. 68, č. 1 (2021), s. 151-158. 2021 IF=1.524; Q3, cit. 1 x |
|---|---|
| 2. | TÓTHOVÁ, Zuzana, SOLÁROVÁ, Zuzana, TOMC, Jana, DEBELJAK, Nataša, SOLÁR, Peter: The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization [elektronický zdroj]. International journal of molecular sciences. - ISSN 1422-0067. - Roč. 22, č. 14 (2021), art. no. 7682, s. [1-14]. - Spôsob prístupu: https://www.mdpi.com/1422-0067/22/14/7682. 10.3390/ijms22147682 2021 IF=6,208; 2021 Q1(Medicine (miscellaneous), cit. 48 x |
| 3. | Zuzana Solárová, Martin Kello, Lenka Varinská, Marianna Budovská, Peter Solár : Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluorophenylamino)- 4H-1,3-thiazine[6,5-b]indole in A2780cis cells. Biomedicine & Pharmacotherapy. - ISSN 0753-3322. - Vol. 85 (2017), p. 463-471. (IF=3,457; Q1 - SJR) cit. 5 x. |
| 4. | SOLÁROVÁ, Zuzana, KELLO, Martin, HAMUĽAKOVÁ, Slávka, MIROSSAY, Ladislav, SOLÁR, Peter: Anti-cancer effect of tacrine-coumarin derivatives on diverse human and mouse cancer cell lines. Acta Chimica Slovenica. - ISSN 1318-0207. - Roč. 65, č. 4 (2018), s. 875-881. 10.17344/acsi.2018.4519 DOI;DOI; WOS; SCOPUS; CCC; IF=1.076; 2018 Q3, cit. 7 x |
| 5. | Solárová Z., Lisková A., Samec M., Kubatka P., Solár P.: Anticancer potential of lichens’ secondary metabolites. Biomolecules – ISSN 2218273X. – Vol. 10, no. 1 (2020), p. (IF=4,879; Q2 - JCR), cit. 26 x. |
VI.3. The most significant research/artistic/other outputs over the last six years
| 1. | Alena Mazuráková a Zuzana Solárová - These authors contributed equally, ACKOVÁ, Lenka, ČAPRNDA, Martin, PROSECKÝ, Róbert, KHAKYMOV, Artur, BARANENKO, Denis, KUBATKA, Peter, MIROSSAY, Ladislav, KRUŽLIAK, Peter, SOLÁR: Heat shock proteins in cancer - Known but always being rediscovered: Their perspectives in cancer immunotherapy. Advances in Medical Sciences. ISSN 1896-1126. - Roč. 68, č. 2 (2023), s. 464-473. 2023 impact factor=2,5; 2023 Q2(Medicine (miscellaneous), cit. 3x |
|---|---|
| 2. | SOLÁROVÁ, Zuzana, KELLO, Martin, SOLÁR, Peter: Apoptotic effect of homobrassinin and thiazino[6,5-b]indol is associated with downregulation of heat shock proteins in human ovarian adenocarcinoma cells. Acta Chimica Slovenica. - ISSN 1318-0207. - Roč. 68, č. 1 (2021), s. 151-158. 2021 IF=1.524; Q3, cit. 1 x |
| 3. | BAGO PILÁTOVÁ, Martina, SOLÁROVÁ, Zuzana, MEZENCEV, Roman, SOLÁR, Peter: Ceramides and their roles in programmed cell death [elektronický zdroj]. Advances in Medical Sciences, ISSN 1898-4002. - Roč. 68, č. 2 (2023), s. 417-425. - Spôsob prístupu: https://www.sciencedirect.com/science/article/pii/S1896112623000445. 2023 impact factor=2,5; Q2(Medicine (miscellaneous), cit. 11 x |
| 4. | Solárová Z., Lisková A., Samec M., Kubatka P., Solár P.: Anticancer potential of lichens’ secondary metabolites. Biomolecules – ISSN 2218273X. – Vol. 10, no. 1 (2020), p. (IF=4,879; Q2 - JCR), cit. 96 x. |
| 5. | TÓTHOVÁ, Zuzana, SOLÁROVÁ, Zuzana, TOMC, Jana, DEBELJAK, Nataša, SOLÁR, Peter: The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization [elektronický zdroj]. International journal of molecular sciences. - ISSN 1422-0067. - Roč. 22, č. 14 (2021), art. no. 7682, s. [1-14]. - Spôsob prístupu: https://www.mdpi.com/1422-0067/22/14/7682. 10.3390/ijms22147682 2021 IF=6,208; 2021 Q1(Medicine (miscellaneous), cit. 48 x |
VI.4. The most significant citations corresponding to research/artistic/other outputs
| 1. | ADC: Solárová Z., Mojžiš J., Solár P.: Hsp90 inhibitor as a sensitizer of cancer cells to different therapies. Int J Oncol 46: 907-926, 2015 (IF=2,773; Q2); cit. 52x Citation: ADC: Pawar, Mercy; Busov, Boris; Chandrasekhar, Aaruran; et al. FAS apoptotic inhibitory molecule 2 is a stress-induced intrinsic neuroprotective factor in the retina Cell Death Differ 24, 1799-1810, 2017 (IF=8,291; Q1) |
|---|---|
| 2. | ADC: Solár P. , Hrčková G. , Koptašíková L. , Velebný S. , Solárová Z. , Bačkor M. : Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: anticancer and hepatoprotective effects of atranorin in vivo. Chemico-Biological Interactions. - ISSN 0009-2797. - Vol. 250 (2016), s. 27-37, (IF=3,143; Q2) cit. 8x Citation: ADC: DEMEČKOVÁ, V. et al. Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer. In Biomedicine and Pharmacotherapy, 2017, vol. 89, s. 245-256. (IF= 3,457, Q1) |
| 3. | ADC. Kimáková P. , Solár P. , Solárová Z. , Komel R. , Debeljak N. : Erythropoietin and its angiogenic activity. International Journal of Molecular Sciences. - ISSN 1422-0067. - Vol. 18, no. 7 (2017), art.no. 1519. (IF=3,687; Q1) cit. 37x Citation: ADC: HAINE, L. et al. Cytoprotective effects of erythropoietin: What about the lung? In Biomedicine and Pharmacotherapy, 2021, vol. 139, art. no. 111547 (IF= 3,457, Q1) |
| 4. | ADC: Solárová Z. , Kello M. , Varinská L. , Budovská M. , Solár P. : Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluorophenylamino)- 4H-1,3-thiazine[6,5-b]indole in A2780cis cells. Biomedicine & Pharmacotherapy. - ISSN 0753-3322. - Vol. 85 (2017), p. 463-471. (IF=3,457; Q1 - SJR) cit. 5 x Citation: ADC: BENITES, J. et al. Targeting Akt as strategy to kill cancer cells using 3-substituted 5-anilinobenzo[c]isoxazolequinones: A preliminary study. In Biomedicine and Pharmacotherapy, 2018, vol. 97, s. 778-783. (IF=3,457; Q1 - SJR) |
| 5. | ADM: Solárová Z., Lisková A., Samec M., Kubatka P., Solár P.: Anticancer potential of lichens’ secondary metabolites. Biomolecules – ISSN 2218273X. – Vol. 10, no. 1 (2020), (IF=4,879; Q2 - JCR), cit. 26 x. Citation: NUGRAHA, Ari Satia - TRIATMOKO, Bawon - WANGCHUK, Phurpa - KELLER, Paul A.. Vascular epiphytic medicinal plants as sources of therapeutic agents: Their ethnopharmacological uses, chemical composition, and biological activities. In Biomolecules, 2020, roč. 10, č. 2. (IF=4,879; Q2 - JCR) |
VI.5. Participation in conducting or leading the most important projects over the last six years
| 1. | APVV-16-0446 Grant name: Cell interactions in tumor microenvironment ant its pharmacologic affecting. Grant supervisor: RNDr. Lenka Varinská, PhD. Duration: 1.7.2017-30.6.2021 Participation: member (2017-2021) |
|---|---|
| 2. | VEGA 1/0536/19 Grant name: The role of erythropoietin receptor in the response of mammary adenocarcinoma cells to paclitaxel in vitro and in vivo. Grant supervisor: Doc. RNDr. Peter Solár, PhD. Duration: 01/2019-12/2022 Participation: member (2019-2023) |
VII. Overview of organizational experience related to higher education and research/artistic/other activities
No records yet.
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
| Institution | Address | Mobility scheme, employment contract, other | Year |
|---|---|---|---|
University in Reykjavik, Iceland | Medical faculty of Reykjavik university | Erasmus teacher's mobility | 2024 – 2024 |
University in Ljubljana, Slovenia | Medical faculty of Ljubljana university | Erasmus teacher's mobility | 2019 – 2019 |
IX. Other relevant facts
No records yet.